New drug atumelnant put to the test in healthy people
NCT ID NCT07221084
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 30 times
Summary
This early-stage study tested the safety and how the body processes a new drug called atumelnant in 21 healthy adults (both Japanese and Caucasian). Participants received either the drug or a placebo. The goal was to measure drug levels and check for side effects, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Crinetics Study Site
Glendale, California, 91206, United States
Conditions
Explore the condition pages connected to this study.